Aavia

Website: https://aavia.io/

Company Description Headquarters: 228 Park Avenue South, Private Mailbox

Aavia is an innovative health-tracking application that places a strong emphasis on educating women about 60414
efficiently managing their hormonal fluctuations. Distinguished as a solution-oriented platform, Aavia empowers New York, NY 10003, US
users by providing personalised insights into their hormone cycles and offering customised recommendations to
improve their overall well-being. The app was established in New York in 2017 by three co-founders with diverse Founders/CEO: Aya Suzuki (Co-Founder)
backgrounds, including females and individuals from minority backgrounds. Alexis Wong (Co-Founder)
Aagya Mathur (Co-Founder and CEO)
Investment Rationale
Aavia's innovative health tracker app uniquely addresses women's health by providing personalised insights into Social Media Handles:
hormonal cycles and adherence to birth control, differentiating it in the competitive health tech landscape. With a https://www.instagram.com/aavia.io/
commendable history of patent activity and recognition from reputable sources like Forbes, Cosmopolitan and MIT, https://www.linkedin.com/company/aavia
Aavia demonstrates a commitment to innovation and credibility in the market. The company's planned launch of
Aavia Pro, expansion into new markets, and current strong market position further enhance its investment appeal,
aligning with IgniteXL's criteria for supporting early-stage ventures with diverse leadership and significant growth Founded: 2017
potential.
Focus Areas: Women's’ Health
Indicators of Progress, Success, and Traction
Aavia's impressive growth metrics include a prominent market position with a projected market size of $3.5 billion in
2023, underscoring its relevance in the birth control pills industry. The company's customer lifetime value (LTV) of Sectors: Longevity/Wellness, Health, Application Software
$219.96, coupled with successful organic and paid acquisition strategies involving platforms like Facebook,
Instagram, and Google, demonstrates robust user engagement. Aavia's expansion plans into new markets, evidenced
by partnerships with Pill Club and the imminent launch of Aavia Pro, further highlight its momentum and potential Disclosed Funding: $3.7-6.9m
for sustained success. Additionally, the company's autonomous user-friendly product, recognition in publications, and
diverse leadership contribute to its compelling growth story. Funding Stage: Seed

Investors: Meridian Street Capital, MIT Delta V,

MassChallenge (Crunchbase)
Aavia
Solution Features
Problem: Aavia addresses the challenge of effectively
managing women's hormonal changes, offering a solution for
timely adherence to birth control pills and monitoring
hormone cycles.
Value Proposition: Aavia empowers women with
personalized insights into their hormone cycles, providing
tailored recommendations for enhanced overall well-being.
Solution/Technology: Aavia's health tracker app, backed by
patented technology, ensures user autonomy without medical
prescriptions. Key features include a planner for optimal
activity scheduling and a competitive $79 smart pill case.
Aavia's diverse founders and strategic intersection of
technology, wellness, and consumer focus reinforce its
unique position. The imminent launch of Aavia Pro and plans
for global expansion underscore the company's commitment
to revolutionizing women's health.
Consumer/Customer/User
Consumer Profile: Aavia's ideal consumer is a tech-savvy
woman seeking comprehensive hormonal health
management without the need for medical prescriptions.
Aavia's user base primarily consists of women seeking
immediate and personalised insights into their hormonal
cycles for overall well-being.
User Experience: Aavia offers an intuitive and user-friendly
experience, allowing women to autonomously manage their
hormonal health. The app's planner feature guides users on
optimal lifestyle choices, and the smart pill case enhances
convenience. The diverse founding team's expertise ensures
a product designed to cater to the unique needs of women,
contributing to the app's recognition in esteemed
publications and its relatively strong market position.
Business Model and Pricing: Aavia generates
revenue by selling its smart pill case and app.
Additionally, it offers Aavia Pro, a subscription
service priced at £9.99 per month or £99.99 per
year. The smart pill case is available for £79, and
the app is free to download. Aavia also
collaborates with birth control delivery services
like Pill Club to expand its reach and
distribution.
Relevant Metrics: Having secured £6.9 million
in funding, Aavia boasts over 10,000 users with
an impressive App Store rating of 4.8. Users
report an 80% improvement in pill adherence, a
50% reduction in stress, and a 70% boost in
confidence. The company prioritizes community
engagement, evident through its website, blog,
podcast, and social media channels. Aavia's
expansion plans into Asia and Europe align with
its aim to meet the high demand for hormone
health solutions globally.
Roadmap: Aavia's upcoming priorities include
the launch of Aavia Pro, a subscription service
with personalized hormone health coaching and
exclusive content, scheduled for early 2024. The
company aims to expand its market presence in
Asia and Europe by replicating successful
partnerships, following its initial collaboration
with Pill Club in the U.S. The focus remains on
fostering a supportive user community through
various online platforms, sustaining its impact
on women's health and well-being.
Name + Title and Background Experience:
•Aya Suzuki (Co-Founder)
•Alexis Wong (Co-Founder)
•Skip Fleshman (Board Member)
•Aagya Mathur (Co-Founder)
•Alaina Andreozzi - Fractional Chief Marketing Officer
The three co-founders make for a diverse founding team:
Mathur had studied neuroscience as an undergrad and thought
she was going to be a doctor until she got into consulting and
decided an MBA at MIT was a better path. Wong was studying
electrical engineering at Hong Kong University, and Suzuki was
an undergraduate at MIT studying mechanical engineering and
design.
Previous Partnership Experience
Pill Club: Aavia has partnered with Pill Club, an online birth control
delivery service, to offer Aavia’s smart pill case and app to Pill
Club’s members. The partnership aims to help women take their
birth control on time and track their health data.
Femtech Collective: Aavia is a member of Femtech Collective, a
network of innovators in the women’s health and wellness
space. Femtech Collective provides Aavia with access to resources,
events, mentorship, and exposure to potential customers and
investors.
Women of Wearables: Aavia is also a member of Women of
Wearables, a global organization that supports and connects women
in wearable tech, fashion tech, health tech, and IoT. Women of
Wearables offers Aavia opportunities to showcase their product,
network with other female founders, and learn from industry experts.
 Investing in Aavia provides IgniteXL Ventures not only with
Aavia lucrative financial prospects but also an opportunity to
make a lasting impact on women's health and well-being.
Risks: The company's impressive journey, diverse leadership,
Market Saturation and Competition: The health tech industry is dynamic and competitive, technological innovation, and market positioning make it a
with the risk of market saturation. Aavia faces competition from established players and compelling investment. Aavia's recognition in reputable
emerging startups. Mitigation: Continuous innovation, strategic partnerships, and maintaining publications and its unique approach to hormonal health
a unique market position. underscores its potential for success. So, I recommend
Regulatory Challenges: Health-related technologies often face evolving regulatory supporting this venture because it aligns seamlessly with
landscapes. A change in regulations may impact Aavia's operations. Mitigation: Regular IgniteXL's mission of enhancing human wellness across all
compliance assessments, legal counsel, and proactive adaptation to regulatory changes. facets of life.
Dependency on Partnerships: Aavia's collaboration with birth control delivery services, like
Pill Club, poses a risk if partnerships dissolve or face challenges. Mitigation: Diversification of
partnerships and establishing contingency plans.
Data Security and Privacy Concerns: Health data is sensitive, and any breaches could lead to Competitive Landscapes
trust issues and legal consequences. Mitigation: Robust cybersecurity measures, compliance
with data protection laws, and transparent communication on data security protocols. How is the company different from
Global Expansion Challenges: Expanding to new markets, particularly in Asia and Europe, its competitors?
presents challenges related to cultural differences, regulatory variations, and market The smart pill case is available on
acceptance. Mitigation: Thorough market research, localized strategies, and adapting services Aavia’s website for $79 and only
to meet regional needs. ships to the U.S. for now. Its
competitor, Emme, sells a smart pill
Company History: case for $99. Other key players in
Diverse and Visionary Founding Team: Aavia's inception in 2017 was marked by a diverse trio of founders – Mathur, Wong, and Suzuki, the hormone health space that
each contributing unique skills and perspectives. Their backgrounds in neuroscience, electrical engineering, and mechanical engineering track and decipher hormones
underscore a visionary approach to women's health. include San Francisco-
Strategic Growth Through Acceleration: The company's journey includes strategic participation in three accelerator/incubator based Modern Fertility, which sells
programs, demonstrating a commitment to continuous learning and growth. This early engagement laid the foundation for Aavia's an at-home fertility test kit that
trajectory in the health tech landscape. requires a blood sample, and
Innovation and Patent Activity: Aavia's notable history of patent activity showcases a commitment to innovation and differentiation. Berlin-based Inne, which sells an at-
This dedication to developing proprietary technology has positioned the company as a leader in leveraging unique solutions within the home, hormone monitoring mini-
health tech space. lab that requires a saliva test.